dr. do on the assessment of tumor response in liver cancer
Published 7 years ago • 194 plays • Length 1:53Download video MP4
Download video MP3
Similar videos
-
0:50
dr. roberts on the prevalence of liver cancer
-
1:57
dr. finn on recent advances in the treatment of liver cancer
-
2:18
dr. finn on biomarkers of response in hcc
-
1:27
dr. sherman on the role of regorafenib in liver cancer
-
1:57
dr. kaseb on the progression of hcc research
-
1:28
dr. yao on the milan criteria in liver cancer
-
4:57
sir-msc (8/24/2017): a brief timeline of hcc tumor response criteria to tace
-
2:55
audio described: clinical trial tests nivolumab for patients with rare brain and spine cancers
-
33:28
assessing response after hepatic interventional oncology
-
5:29
trends and risk factors in liver cancer
-
3:38
biomarkers in liver cancer
-
1:19
dr. greten discusses the impact of the gut microbiome on liver tumors
-
32:55
innovating liver cancer treatment: expert q&a
-
4:56
liver cancer - causes, signs & symptoms, diagnosis, treatment | dr tan hon lyn (medical oncologist)
-
8:46
understanding bclc criteria in liver cancer staging
-
10:35
liver cancer by surged
-
1:47
dr. finn discusses the role of lenvatinib in liver cancer
-
4:52
role of tace in liver cancer
-
5:45
liver cancer - liver function, vulnerability, early detection | dr. lee guan huei (hepatologist)